Bruce Keyt - Apr 18, 2023 Form 4 Insider Report for IGM Biosciences, Inc. (IGMS)

Role: Chief Scientific Officer
Signature: /s/ Fred Schwarzer, by power of attorney
Stock symbol: IGMS
Transactions as of: Apr 18, 2023
Transactions value $: $0
Form type: 4
Date filed: 4/20/2023, 08:54 PM
Previous filing: Apr 6, 2023
Next filing: May 25, 2023

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	IGMS	Common Stock	Award	$0	+21.1K	+18.06%	$0.00	138K	Apr 18, 2023	Direct	F1
holding	IGMS	Common Stock						1.01K	Apr 18, 2023	See footnote	F2

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.
F2	The shares are held directly by the Reporting Person's spouse.

Content

These securities are restricted stock units (RSUs), granted pursuant to the election by the Reporting Person to receive RSUs in lieu of an earned cash bonus for performance in fiscal year 2022. Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. 100% of the RSUs shall vest in December 2023, provided that the Reporting Person remains a service provider through the vesting date.

The shares are held directly by the Reporting Person's spouse.